| Annual Financials | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 0 | 2,408 | 2,363 | 2,398 | 2,479 | 3,000 | 3,046 | 3,614 | 3,925 | 3,959 | 4,258 | 3,412 | 4,357 |
| Expenses | 0 | 1,849 | 1,670 | 1,656 | 1,840 | 2,338 | 2,398 | 2,690 | 3,071 | 3,049 | 3,235 | 2,503 | 3,174 |
| EBITDA | 0 | 559 | 693 | 742 | 640 | 663 | 648 | 924 | 854 | 909 | 1,023 | 908 | 1,182 |
| Operating Profit % | 0 % | 21 % | 27 % | 29 % | 25 % | 21 % | 20 % | 25 % | 21 % | 22 % | 23 % | 26 % | 26 % |
| Depreciation | 0 | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 57 | 32 | 41 |
| Interest | 0 | 6 | 6 | 10 | 5 | 6 | 6 | 6 | 11 | 11 | 27 | 14 | 14 |
| Profit Before Tax | 0 | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 840 | 939 | 862 | 1,127 |
| Tax | 0 | 155 | 213 | 239 | 207 | 188 | 161 | 218 | 214 | 161 | 264 | 226 | 300 |
| Net Profit | 0 | 346 | 423 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 829 |
| EPS in ₹ | 0.00 | 106.63 | 130.16 | 133.31 | 115.40 | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 196.11 | 255.30 |
P&G Hygiene and Health Care
P&G Hygiene and Health Care
13,604.00
-101.00
(-0.74%)
Key Fundamentals
Market Cap
44,159.59 Cr
EPS
196.11
PE Ratio
53.68
Dividend Yield
1.28 %
Industry
Consumer Goods 52 Week High
16,572.00
52 Week Low
12,105.60
PB Ratio
60.36
Debt to Equity
0.00
Sector
Personal Care Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
Procter & Gamble Hygiene & Health Care Ltd. completed a block trade worth Rs. 100.06 crores on the National Stock Exchange. The transaction involved approximately 75,572 shares at a price of Rs. 13,240 per share.
Procter & Gamble Hygiene and Health Care Re-appoints Two Independent Directors for Five-Year TermsJul 30, 2025
Procter & Gamble Hygiene and Health Care Limited's Board of Directors has approved the re-appointment of two Independent Directors for five-year terms. Mr. Krishnamurthy Iyer will serve from December 1, 2025 to November 30, 2030, while Mr. Chittranjan Dua will serve from August 25, 2025 to August 24, 2030. Both re-appointments follow the completion of their first tenure and are subject to shareholder approval at the upcoming annual general meeting. The company confirmed that both directors meet independence criteria under the Companies Act, 2013 and SEBI regulations, are not disqualified from holding director positions, and do not hold any shares in the company. Neither director has any relationship with other company directors.
Procter & Gamble Hygiene & Health Care Reports Strong Q1 Performance with EBITDA More Than Doubling
Jul 30, 2025
Jul 30, 2025Procter & Gamble Hygiene & Health Care delivered robust quarterly results with EBITDA rising to 2.66 billion rupees from 1.2 billion rupees year-over-year. The company's EBITDA margin expanded significantly to 28.41% compared to 12.7% in the same period last year. Net profit increased to 1.92 billion rupees from 811 million rupees year-over-year, while revenue grew marginally to 9.4 billion rupees from 9.3 billion rupees.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,120.50 | #1 1,14,635.48 | 62.60 | #1 14,680.40 | 2.19 | #1 1,852 | 0.40 | 39.57 | |
500.00 | 88,684.51 | 51.68 | 13,113.20 | 1.76 | 1,740 | 2.81 | 51.33 | |
2,207.00 | 60,027.23 | 44.68 | 6,179.00 | 7.33 | 1,437 | -17.09 | 48.98 | |
13,604.00 | #4 44,159.59 | #5 53.68 | #5 3,411.80 | #10 -19.87 | #5 637 | #1 136.87 | 48.92 | |
9,253.00 | 30,151.10 | 53.90 | 2,262.80 | -14.91 | 418 | 25.60 | 40.76 | |
541.05 | 23,616.83 | #1 29.24 | 3,877.30 | 6.96 | 803 | 9.10 | 42.51 | |
271.95 | 8,848.43 | 120.93 | 2,145.70 | 8.94 | 73 | 2.48 | 40.69 | |
239.15 | 6,420.39 | 136.02 | 203.20 | 13.97 | 41 | 80.72 | 76.63 | |
268.61 | 3,681.38 | 30.96 | 1,000.40 | -2.76 | 125 | 2.16 | 70.06 | |
192.45 | 288.83 | 101.27 | 48.30 | #1 45.92 | 3 | 20.00 | 50.99 |
Growth Rate
Revenue Growth
-19.87 %
Net Income Growth
-5.69 %
Cash Flow Change
26.21 %
ROE
-0.85 %
ROCE
-6.71 %
EBITDA Margin (Avg.)
10.87 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,948 | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 |
| Fixed Assets | 309 | 309 | 317 | 286 | 250 | 234 | 207 | 184 | 164 | 170 | 139 | 131 |
| Current Assets | 1,356 | 1,357 | 1,632 | 603 | 815 | 1,090 | 1,328 | 1,117 | 1,135 | 1,496 | 1,200 | 1,091 |
| Capital Work in Progress | 39 | 39 | 35 | 41 | 22 | 15 | 22 | 38 | 44 | 23 | 28 | 41 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,600 | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 |
| Total Liabilities | 1,948 | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 |
| Current Liabilities | 599 | 716 | 511 | 582 | 571 | 643 | 595 | 836 | 860 | 1,085 | 981 | 901 |
| Non Current Liabilities | 3 | 3 | 4 | 52 | 49 | 66 | 76 | 83 | 85 | 106 | 103 | 117 |
| Total Equity | 1,346 | 1,229 | 1,652 | 526 | 806 | 909 | 1,158 | 714 | 738 | 946 | 775 | 737 |
| Reserve & Surplus | 1,313 | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 |
| Share Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 |
| Investing Activities | 28 | 221 | 149 | -20 | 34 | 75 | 7 | -27 | -10 | 1 | -34 |
| Operating Activities | 426 | 353 | 445 | 416 | 413 | 474 | 863 | 573 | 826 | 470 | 593 |
| Financing Activities | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -666 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.30 % | 1.48 % | 1.57 % | 1.56 % | 1.48 % | 1.43 % | 1.33 % | 1.38 % |
| DIIs | 13.30 % | 13.30 % | 13.20 % | 13.19 % | 13.60 % | 13.91 % | 14.37 % | 15.28 % | 15.33 % | 15.43 % | 15.44 % | 15.29 % | 15.11 % | 15.16 % | 15.28 % | 15.37 % | 15.51 % | 15.49 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 10.63 % | 10.58 % | 10.57 % | 10.52 % | 10.43 % | 10.37 % | 10.34 % | 10.22 % | 10.15 % | 10.04 % | 9.90 % | 9.88 % | 9.92 % | 9.87 % | 9.80 % | 9.76 % | 9.76 % | 9.74 % |
| Others | 5.43 % | 5.48 % | 5.59 % | 5.65 % | 5.32 % | 5.08 % | 4.65 % | 3.87 % | 3.89 % | 3.89 % | 2.72 % | 2.71 % | 2.76 % | 2.77 % | 2.80 % | 2.80 % | 2.76 % | 2.75 % |
| No of Share Holders | 39,337 | 39,806 | 41,120 | 40,908 | 40,819 | 41,533 | 43,445 | 40,495 | 39,968 | 39,388 | 37,069 | 38,807 | 39,999 | 40,671 | 42,348 | 42,941 | 44,877 | 47,891 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 389 | 40 | 88 | 105 | 315 | 160 | 185 | 255 | 175 |
| Dividend Yield (%) | 0.00 | 4.07 | 0.37 | 0.86 | 0.83 | 2.19 | 1.2 | 1.09 | 1.87 | 1.28 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 Nov 2025 |  Quarterly Result Announcement | NA | 06 Nov 2025 | 13,648.00 | 13,704.45 |
| 11 Feb 2021 |  Dividend | ₹ 85.00 /share | 10 Feb 2021 | 11,128.35 | 12,537.60 |
| 12 May 2021 | Dividend | ₹ 150.00 /share | 11 May 2021 | 13,542.15 | 13,691.15 |
| 11 Nov 2021 | Dividend | ₹ 80.00 /share | 09 Nov 2021 | 13,038.55 | 14,440.35 |
| 09 Feb 2022 | Dividend | ₹ 95.00 /share | 08 Feb 2022 | 14,803.60 | 15,222.00 |
| 09 Nov 2022 | Dividend | ₹ 65.00 /share | 04 Nov 2022 | 14,597.50 | 14,082.15 |
| 08 Feb 2023 | Dividend | ₹ 80.00 /share | 08 Feb 2023 | 13,756.20 | 13,647.30 |
| 18 Nov 2023 | Dividend | ₹ 105.00 /share | 17 Nov 2023 | 15,492.15 | 18,427.55 |
| 24 Nov 2023 |  Annual General Meeting | NA | 24 Nov 2023 | 15,492.15 | 17,900.30 |
| 09 Feb 2024 | Dividend | ₹ 60.00 /share | 09 Feb 2024 | 17,165.60 | 16,581.70 |
| 09 Feb 2024 | Dividend | ₹ 100.00 /share | 09 Feb 2024 | 17,165.60 | 16,581.70 |
| 30 Oct 2024 | Quarterly Result Announcement | NA | 30 Oct 2024 | 16,417.60 | 16,418.55 |
| 20 Nov 2024 | Dividend | ₹ 95.00 /share | 19 Nov 2024 | 17,017.65 | 15,803.50 |
| 26 Nov 2024 | Annual General Meeting | NA | 26 Nov 2024 | 17,017.65 | 15,909.90 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 14,776.50 | 14,101.70 |
| 20 Feb 2025 | Dividend | ₹ 110.00 /share | 20 Feb 2025 | 14,101.70 | 14,004.85 |
| 27 May 2025 | Quarterly Result Announcement | NA | 27 May 2025 | 13,916.05 | 14,234.40 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 13,421.00 | 13,083.65 |
| 28 Aug 2025 | Dividend | ₹ 65.00 /share | 28 Aug 2025 | 14,234.40 | 13,118.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 14,232.00 | 13,485.90 |
Announcements
Revision of Board Meeting8 days ago
8 days agoClosure of Trading WindowSep 29, 2025
Sep 29, 2025Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 6 2025
Sep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 05, 2025
Sep 05, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 13, 2025
Aug 13, 2025Record Date For Annual General Meeting And DividendAug 13, 2025
Aug 13, 2025Annual General Meeting And Annual Report For The Financial Year 2024-25Aug 13, 2025
Aug 13, 2025Press ReleaseJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 30, 2025
Jul 30, 2025Board Meeting Outcome for Unaudited Results For The Quarter Ended June 30 2025Jul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 23, 2025
Jul 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 302025Jun 27, 2025
Jun 27, 2025Change In Senior Management PersonnelJun 23, 2025
Jun 23, 2025Change In Chief Financial Officer Of The CompanyJun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 12, 2025
Jun 12, 2025Presentation For The Analyst/ Investor MeetJun 12, 2025
Jun 12, 2025Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited (The Company)Jun 06, 2025
Jun 06, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
May 28, 2025Annual General MeetingMay 28, 2025
May 28, 2025Board Meeting Outcome for Audited Financial Results Dividend And Appointment Of Secretarial AuditorMay 27, 2025
May 27, 2025Change In Communication Details Of The Registrar And Transfer AgentApr 25, 2025
Apr 25, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 16, 2025
Apr 16, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results And Statements For The Financial Year Ended March 312025 And To Consider Recommendation Of Dividend If Any.Mar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Integrated Filing (Financial)Feb 18, 2025
Feb 18, 2025Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited (The Company)Feb 11, 2025
Feb 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 11, 2025
Feb 11, 2025Corporate Action-Board approves DividendFeb 11, 2025
Feb 11, 2025Unaudited Financial Results For The Quarter Ended December 312024Feb 11, 2025
Feb 11, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 312024 And Interim Dividend 2024-25Feb 11, 2025
Feb 11, 2025Update on board meetingJan 31, 2025
Jan 31, 2025Corporate Action-Board to consider DividendJan 31, 2025
Jan 31, 2025Update On Purpose Of Board MeetingJan 31, 2025
Jan 31, 2025Intimation Regarding Change Of The Financial Year Of The CompanyJan 23, 2025
Jan 23, 2025Intimation regarding Change of the Financial Year of the CompanyJan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Jan 14, 2025Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter Ended December 312024Dec 27, 2024
Dec 27, 2024Closure of Trading WindowDec 27, 2024
Dec 27, 2024Mutual Fund Holdings
ICICI Prudential Large Cap Fund Direct-Growth 
SBI Focused Fund Direct Plan-Growth 
Sundaram Mid Cap Fund Direct-Growth 
UTI BSE Low Volatility Index Fund Direct - Growth 
Franklin India Dividend Yield Fund Direct-Growth 
Motilal Oswal Nifty Midcap 150 Index Fund Direct - Growth 
Nippon India Nifty Midcap 150 Index Fund Direct - Growth 
Aditya Birla Sun Life MNC Fund Direct-Growth 
LIC MF Large & Mid Cap Fund Direct-Growth 
Zerodha Nifty Large Midcap 250 Index Fund Direct - Growth 
HDFC NIFTY Midcap 150 Index Fund Direct - Growth 
Navi Nifty Midcap 150 Index Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 44.46
ATR(14)
Less Volatile 285.84
STOCH(9,6)
Neutral 24.74
STOCH RSI(14)
Oversold 7.03
MACD(12,26)
Bearish -81.92
ADX(14)
Strong Trend 27.97
UO(9)
Bearish 43.67
ROC(12)
Downtrend And Accelerating -4.69
WillR(14)
Oversold -93.60
About P&G Hygiene and Health Care
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is an Indian company that manufactures and sells branded fast-moving consumer goods in the feminine care and healthcare sectors. The company operates in two segments: healthcare products (ointments, creams, cough drops, and tablets) and hygiene products (feminine hygiene and skin care). Its brand portfolio includes Whisper, Vicks, and Old Spice. P&GHHCL's products are sold through various retail channels including mass merchandisers, grocery stores, club stores, drug stores, department stores, and high-frequency stores. The company has manufacturing facilities in Goa and Baddi, Himachal Pradesh, as well as third-party manufacturing locations across India.
Website
Chairperson NameChittranjan Dua
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
